Genome-based therapeutics : targeted drug discovery and development /

The goal of the workshop will be to discuss how genomic and genetic data has been and will be used in the drug development process to improve aspects such as target identification, clinical trial design, pharmacogenomics approaches, biomarker development, and understanding disease biology. The works...

Full description

Saved in:
Bibliographic Details
Online Access: http://www.ncbi.nlm.nih.gov/books/NBK100304/
Full text
Corporate Author: Institute of Medicine (U.S.). Roundtable on Translating Genomic-Based Research for Health
Other Authors: Berger, Adam C., Olson, Steve, 1956-
Format: Electronic eBook
Language:English
Published: Washington, D.C. : National Academies Press, 2012
Subjects:

MARC

LEADER 00000cam a2200000 a 4500
001 p2439876
005 20240212122520.0
006 m d
007 cr un ||||||||
008 130129t20122012dcua ob 100 0 eng
020 |a 9780309260244 
020 |a 0309260248 
035 |a (DNLM)BKSHLF:NBK100304 
035 |a 1601251 
040 |a DNLM  |c DNLM  |d UtOrBLW 
041 0 |a eng 
042 |a pcc 
060 1 0 |a QV 745 
245 0 0 |a Genome-based therapeutics :  |b targeted drug discovery and development /  |c Adam C. Berger and Steve Olson, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy Institute of Medicine of the National Academies. 
264 1 |a Washington, D.C. :  |b National Academies Press,  |c [2012] 
264 4 |c ©2012 
300 |a 1 online resource (1 PDF file (xx, 89 pages)) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
520 3 |a The goal of the workshop will be to discuss how genomic and genetic data has been and will be used in the drug development process to improve aspects such as target identification, clinical trial design, pharmacogenomics approaches, biomarker development, and understanding disease biology. The workshop will also investigate the economic drivers, incentives, and models that use genomics in drug development. 
530 |a Issued also in print. 
536 |a This project was supported by contracts between the National Academy of Sciences and the American College of Medical Genetics and Genomics (unnumbered contract); American Heart Association (unnumbered contract); American Medical Association (unnumbered contract); American Society of Human Genetics (unnumbered contract); Blue Cross and Blue Shield Association (unnumbered contract); Centers for Disease Control and Prevention (Contract No. 200-2011-38807); College of American Pathologists (unnumbered contract); Department of the Air Force (Contract No. FA7014-10-P-0072); Department of Veterans Affairs (Contract No. V101(93) P-2238); Eli Lilly and Company (Contract No. LRL-0028-07); Genetic Alliance (unnumbered contract); Health Resources and Services Administration (Contract No. HHSH250201100119P); Johnson & Johnson (unnumbered contract); Kaiser Permanente Program Offices Community Benefit II at the East Bay Community Foundation (Contract No. 20121257); Life Technologies (unnumbered contract); National Cancer Institute (Contract No. N01-OD-4-2139, TO#189); National Coalition for Health Professional Education in Genetics (unnumbered contract); National Heart, Lung, and Blood Institute (Contract No. N01-OD-4-2139, TO#275); National Human Genome Research Institute (Contract No. N01-OD-4-2139, TO#264); National Institute of Mental Health (Contract No. N01-OD-4-2139, TO#275); National Institute on Aging (Contract No. N01-OD-4-2139, TO#275); National Society of Genetic Counselors (unnumbered contract); Office of Rare Diseases Research (Contract No. N01-OD-4-2139, TO#275); and Pfizer Inc. (Contract No. 140-N-1818071). 
650 1 2 |a Drug Discovery.  |0 D055808 
655 2 |a Congress.  |0 D016423 
700 1 |a Berger, Adam C.  |0 no2010177254 
700 1 |a Olson, Steve,  |d 1956-  |0 n 85025654  
710 2 |a Institute of Medicine (U.S.).  |b Roundtable on Translating Genomic-Based Research for Health.  |0 no2008119550 
856 4 0 |u http://www.ncbi.nlm.nih.gov/books/NBK100304/  |t 0 
951 |a 2439876 
998 |a BKSHLF  |b 20130129 
999 f f |i 8c4c4ba9-7825-51d8-a23a-5ebe5fb9740c  |s 82a1e5e9-9f32-52ca-a68b-b2a880ffe691  |t 0 
952 f f |a Massachusetts College of Pharmacy and Health Sciences  |b Online  |c Online  |d E-Collections  |t 0  |e NCBI  |h Other scheme 
856 4 0 |t 0  |u http://www.ncbi.nlm.nih.gov/books/NBK100304/  |y Full text